BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16133379)

  • 1. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow.
    Kazama T; Swanston N; Podoloff DA; Macapinlac HA
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1406-11. PubMed ID: 16133379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.
    Sugawara Y; Fisher SJ; Zasadny KR; Kison PV; Baker LH; Wahl RL
    J Clin Oncol; 1998 Jan; 16(1):173-80. PubMed ID: 9440740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
    Hanaoka K; Hosono M; Usami K; Tatsumi Y; Yamazoe Y; Komeya Y; Tsuchiya N; Ishii K; Sumita M
    Nucl Med Commun; 2011 Aug; 32(8):678-83. PubMed ID: 21499162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
    Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
    Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography.
    Mayer D; Bednarczyk EM
    Ann Pharmacother; 2002 Nov; 36(11):1796-9. PubMed ID: 12398579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
    Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT.
    Murata Y; Kubota K; Yukihiro M; Ito K; Watanabe H; Shibuya H
    Nucl Med Biol; 2006 Nov; 33(8):999-1004. PubMed ID: 17127173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
    Doot RK; Dunnwald LK; Schubert EK; Muzi M; Peterson LM; Kinahan PE; Kurland BF; Mankoff DA
    J Nucl Med; 2007 Jun; 48(6):920-5. PubMed ID: 17504870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of bone marrow
    Lee JW; Lee SC; Kim HJ; Lee SM
    Hell J Nucl Med; 2017; 20(1):17-25. PubMed ID: 28315904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing the interval between G-CSF therapy and F-18 FDG PET imaging in children and young adults receiving chemotherapy for sarcoma.
    Trout AT; Sharp SE; Turpin BK; Zhang B; Gelfand MJ
    Pediatr Radiol; 2015 Jul; 45(7):1001-6. PubMed ID: 25646737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results.
    Sugawara Y; Zasadny KR; Kison PV; Baker LH; Wahl RL
    J Nucl Med; 1999 Sep; 40(9):1456-62. PubMed ID: 10492365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin.
    Blodgett TM; Ames JT; Torok FS; McCook BM; Meltzer CC
    Clin Nucl Med; 2004 Mar; 29(3):161-3. PubMed ID: 15162984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
    Elicin O; Callaway S; Prior JO; Bourhis J; Ozsahin M; Herrera FG
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1099-107. PubMed ID: 25442041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhomogeneous bone marrow uptake caused by G-CSF mimics multiple bone metastases on FDG-PET.
    Nakamoto Y; Suga T; Hara T; Ishizu K; Togashi K
    Clin Nucl Med; 2010 Feb; 35(2):74-6. PubMed ID: 20090448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
    Rose BS; Liang Y; Lau SK; Jensen LG; Yashar CM; Hoh CK; Mell LK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1185-91. PubMed ID: 22270171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Splenic and bone marrow increased 18F-FDG uptake in a PET scan performed following treatment with G-CSF].
    Ruiz-Hernández G; Scaglione C; Delgado-Bolton RC; Gutiérrez-García A; Madero L; Jiménez-Vicioso A; Carreras-Delgado JL
    Rev Esp Med Nucl; 2004; 23(2):124-6. PubMed ID: 15000944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels.
    Van de Wiele C; VandeVyver F; Debruyne C; Philippé J; van Meerbeeck JP
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):519-22. PubMed ID: 18034241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased FDG bone marrow uptake after intracoronary progenitor cell therapy.
    Döbert N; Menzel C; Diehl M; Hamscho N; Zaplatnikov K; Grünwald F
    Nuklearmedizin; 2005 Feb; 44(1):15-9. PubMed ID: 15711724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.